Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Lunec
P53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma
Cancer Research
Cancer Research
Oncology
Disturbed Handling of Ascorbic Acid in Diabetic Patients With and Without Microangiopathy During High Dose Ascorbate Supplementation
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Cellular Retinoic Acid–Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma
Cancer Research
Cancer Research
Oncology
Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma
Oncotarget
Oncology
ABCC4/MRP4: A MYCN-regulated Transporter and Potential Therapeutic Target in Neuroblastoma
Frontiers in Oncology
Cancer Research
Oncology
PRIMA-1MET-induced Neuroblastoma Cell Death Is Modulated by P53 and Mycn Through Glutathione Level
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
D133p53 Isoform Is a Direct P53 Target Gene That Modulates P53 Tumour Suppressor Activity
Breast Cancer Research
Cancer Research
Oncology
Ribosomal Protein S27L Is a Direct P53 Target That Regulates Apoptosis
Oncogene
Cancer Research
Genetics
Molecular Biology
Phox2B Correlates With MYCN and Is a Prognostic Marker for Neuroblastoma Development
Oncology Letters
Cancer Research
Oncology
Long Non-Coding RNA NEAT1 Is a Transcriptional Target of P53 and Modulates P53-Induced Transactivation and Tumor-Suppressor Function
International Journal of Cancer
Cancer Research
Oncology
Glutathione Biosynthesis Is Upregulated at the Initiation of MYCN-driven Neuroblastoma Tumorigenesis
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
